Airway smooth muscle: A potential target for asthma therapy

Current Opinion in Pulmonary Medicine

Volumn 20, Issue 1, 2014, Pages 66-72

  Dowell, Maria L ^a   Lavoie, Tera L ^a   Solway, Julian ^a   Krishnan, Ramaswamy ^b  

^a UNIVERSITY OF CHICAGO   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

Author keywords

airway smooth muscle; asthma; bronchodilation; therapeutic targets

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR; CYCLIC AMP; CYCLIC AMP DEPENDENT PROTEIN KINASE; GERANYLTRANSFERASE; HEAT SHOCK PROTEIN 20; HEAT SHOCK PROTEIN 27; INTERLEUKIN 13; INTERLEUKIN 17; MUSCARINIC M3 RECEPTOR; MYOSIN LIGHT CHAIN KINASE; POTASSIUM CHANNEL; PROSTAGLANDIN E RECEPTOR;

ACTIN FILAMENT; ACTIN POLYMERIZATION; AIRWAY SMOOTH MUSCLE; ASTHMA; BREATHING MUSCLE; BRONCHODILATATION; BRONCHOSPASM; DESENSITIZATION; HUMAN; MEMBRANE STEADY POTENTIAL; MORBIDITY; MORTALITY; NONHUMAN; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN POLYMERIZATION; QUALITY OF LIFE; REVIEW; SMOOTH MUSCLE; SMOOTH MUSCLE CONTRACTION; SMOOTH MUSCLE RELAXATION; TACHYPHYLAXIS; TIDAL VOLUME;

ANTI-ASTHMATIC AGENTS; ASTHMA; BRONCHOCONSTRICTION; BRONCHODILATOR AGENTS; HUMANS; MUSCLE CONTRACTION; MUSCLE, SMOOTH; RESPIRATORY SYSTEM; SIGNAL TRANSDUCTION;

EID: 84890116633     PISSN: 10705287     EISSN: 15316971     Source Type: Journal    
DOI: 10.1097/MCP.0000000000000011     Document Type: Review

References (62)

1. An SS, Bai TR, Bates JH, et al. Airway smooth muscle dynamics: A common pathway of airway obstruction in asthma. Eur Respir J 2007; 29:834-860
2. Amrani Y, Panettieri RA. Airway smooth muscle: Contraction and beyond. Int J Biochem Cell Biol 2003; 35:272-276
3. Antonissen LA, Mitchell RW, Kroeger EA, et al. Mechanical alterations of airway smooth muscle in a canine asthmatic model. J Appl Physiol 1979; 46:681-687
4. Fredberg JJ, Inouye DS, Mijailovich SM, Butler JP. Perturbed equilibrium of myosin binding in airway smooth muscle and its implications in bronchospasm. Am J Respir Crit Care Med 1999; 159:959-967
5. Gunst SJ, Tang DD. The contractile apparatus and mechanical properties of airway smooth muscle. Eur Respir J 2000; 15:600-616
6. Lambert RK, Pare PD. Lung parenchymal shear modulus, airway wall remodeling, and bronchial hyperresponsiveness. J Appl Physiol 1997; 83:140-147
7. Macklem PT. A theoretical analysis of the effect of airway smooth muscle load on airway narrowing. Am J Respir Crit Care Med 1996; 153:83-89
8. Solway J, Irvin CG. Airway smooth muscle as a target for asthma therapy. N Engl J Med 2007; 356:1367-1369
9. Barnes PJ. New drugs for asthma. Nat Rev Drug Discov 2004; 3:831-844
10. Webb S. Attacks on asthma. Nat Biotechnol 2011; 29:860-863
11. Chapman KR, Boulet LP, Rea RM, Franssen E. Suboptimal asthma control: Prevalence, detection and consequences in general practice. Eur Respir J 2008; 31:320-325
12. Wright DB, Trian T, Siddiqui S, et al. Functional phenotype of airway myocytes from asthmatic airways. Pulm Pharmacol Ther 2013; 26:95-104
13. Nelson HS, Dorinsky PM. Safety of long-Acting beta-Agonists. Ann Intern Med 2006; 145:706
14. Lipworth BJ. Airway subsensitivity with long-Acting beta 2-Agonists. Is there cause for concern? Drug Saf 1997; 16:295-308
15. Shore SA, Drazen JM. Beta-Agonists and asthma: Too much of a good thing? J Clin Invest 2003; 112:495-497
16. Israel E, Drazen JM, Liggett SB, et al. The effect of polymorphisms of the beta(2)-Adrenergic receptor on the response to regular use of albuterol in asthma. Am J Respir Crit Care Med 2000; 162:75-80
17. Jiang X, Pan H, Nabhan JF, et al. A novel EST-Derived RNAi screen reveals a critical role for farnesyl diphosphate synthase in beta2-Adrenergic receptor internalization and down-regulation. FASEB J 2012; 26:1997-2007
18. Benyahia C, Gomez I, Kanyinda L, et al. PGE(2) receptor (EP(4)) agonists: Potent dilators of human bronchi and future asthma therapy? Pulm Pharmacol Ther 2012; 25:115-118
19. Wasiak W, Szmidt M. A six week double blind, placebo controlled, crossover study of the effect of misoprostol in the treatment of aspirin sensitive asthma. Thorax 1999; 54:900-904
20. Buckley J, Birrell MA, Maher SA, et al. EP4 receptor as a new target for bronchodilator therapy. Thorax 2011; 66:1029-1035
21. Deshpande DA, Wang WC, McIlmoyle EL, et al. Bitter taste receptors on airway smooth muscle bronchodilate by localized calcium signaling and reverse obstruction. Nat Med 2010; 16:1299-1304
22. Liggett SB. Bitter taste receptors on airway smooth muscle as targets for novel bronchodilators. Expert Opin Ther Targets 2013; 17:721-731
23. An SS, Wang WC, Koziol-White CJ, et al. TAS2R activation promotes airway smooth muscle relaxation despite beta(2)-Adrenergic receptor tachyphylaxis. Am J Physiol Lung Cell Mol Physiol 2012; 303:L304-L311
24. Robinett KS, Deshpande DA, Malone MM, Liggett SB. Agonist-promoted homologous desensitization of human airway smooth muscle bitter taste receptors. Am J Respir Cell Mol Biol 2011; 45:1069-1074
25. Morice AH, Bennett RT, Chaudhry MA, et al. Effect of bitter tastants on human bronchi. Nat Med 2011; 17:775
26. McGraw DW, Elwing JM, Fogel KM, et al. Crosstalk between Gi and Gq/Gs pathways in airway smooth muscle regulates bronchial contractility and relaxation. J Clin Invest 2007; 117:1391-1398
27. Muers H, Roffel AF, Elzinga CRS, Zaagsma J. Muscarinic receptor-betaadrenoreceptor crosstalk in airway smooth muscle. In: Zaagsma J, Meurs H, Roffel AF, editors. Muscarinic receptors in airways diseases. Basel: Birkhäuser Verlag; 2001. pp. 121-158
28. Cazzola M, Page C, Matera MG. Long-Acting muscarinic receptor antagonists for the treatment of respiratory disease. Pulm Pharmacol Ther 2013; 26:307-317
29. Kerstjens HA, Disse B, Schroder-Babo W, et al. Tiotropium improves lung function in patients with severe uncontrolled asthma: A randomized controlled trial. J Allergy Clin Immunol 2011; 128:308-314
30. Billington CK, Ojo OO, Penn RB, Ito S. cAMP regulation of airway smooth muscle function. Pulm Pharmacol Ther 2013; 26:112-120
31. Mak G, Hanania NA. New bronchodilators. Curr Opin Pharmacol 2012; 12:238-245
32. Gauvreau GM, Boulet LP, Schmid-Wirlitsch C, et al. Roflumilast attenuates allergen-induced inflammation in mild asthmatic subjects. Respir Res 2011; 12:140
33. Salinthone S, Tyagi M, Gerthoffer WT. Small heat shock proteins in smooth muscle. Pharmacol Ther 2008; 119:44-54
34. Komalavilas P, Penn RB, Flynn CR, et al. The small heat shock-related protein, HSP20, is a cAMP-Dependent protein kinase substrate that is involved in airway smooth muscle relaxation. Am J Physiol Lung Cell Mol Physiol 2008; 294:L69-L78
35. Dreiza CM, Brophy CM, Komalavilas P, et al. Transducible heat shock protein 20 (HSP20) phosphopeptide alters cytoskeletal dynamics. FASEB J 2005; 19:261-263
36. Ba M, Singer CA, Tyagi M, et al. HSP20 phosphorylation and airway smooth muscle relaxation. Cell Health Cytoskelet 2009; 2009:27-42
37. An SS, Askovich PS, Zarembinski TI, et al. A novel small molecule target in human airway smooth muscle for potential treatment of obstructive lung diseases: A staged high-Throughput biophysical screening.Respir Res2011; 12:8
38. Brueggemann LI, Kakad PP, Love RB, et al. Kv7 potassium channels in airway smooth muscle cells: Signal transduction intermediates and pharmacological targets for bronchodilator therapy. Am J Physiol Lung Cell Mol Physiol 2012; 302:L120-L132
39. Fukata Y, Amano M, Kaibuchi K. Rho-Rho-kinase pathway in smooth muscle contraction and cytoskeletal reorganization of nonmuscle cells. Trends Pharmacol Sci 2001; 22:32-39
40. Oguma T, Kume H, Ito S, et al. Involvement of reduced sensitivity to Ca in betaadrenergic action on airway smooth muscle. Clin Exp Allergy 2006; 36:183-191
41. Schaafsma D, Gosens R, Zaagsma J, et al. Rho kinase inhibitors: A novel therapeutical intervention in asthmä Eur J Pharmacol 2008; 585:398-406
42. Gosens R, Schaafsma D, Nelemans SA, Halayko AJ. Rho-kinase as a drug target for the treatment of airway hyperresponsiveness in asthma. Mini Rev Med Chem 2006; 6:339-348
43. Chiba Y, Sato S, Misawa M. Inhibition of antigen-induced bronchial smooth muscle hyperresponsiveness by lovastatin in mice. J Smooth Muscle Res 2008; 44:123-128
44. Menzies D, Nair A, Meldrum KT, et al. Simvastatin does not exhibit therapeutic anti-inflammatory effects in asthma. J Allergy Clin Immunol 2007; 119:328-335
45. Tliba O, Deshpande D, Chen H, et al. IL-13 enhances agonist-evoked calcium signals and contractile responses in airway smooth muscle. Br J Pharmacol 2003; 140:1159-1162
46. Risse PA, Jo T, Suarez F, et al. Interleukin-13 inhibits proliferation and enhances contractility of human airway smooth muscle cells without change in contractile phenotype. Am J Physiol Lung Cell Mol Physiol 2011; 300: L958-L966
47. Kudo M, Melton AC, Chen C, et al. IL-17A produced by alphabeta T cells drives airway hyper-responsiveness in mice and enhances mouse and human airway smooth muscle contraction. Nat Med 2012; 18:547-554
48. Corren J, Lemanske RF, Hanania NA, et al. Lebrikizumab treatment in adults with asthma. N Engl J Med 2011; 365:1088-1098
49. Polosa R, Casale T. Monoclonal antibodies for chronic refractory asthma and pipeline developments. Drug Discov Today 2012; 17:591-599
50. Sheshadri A, Castro M, Chen A. Bronchial thermoplasty: A novel therapy for severe asthma. Clin Chest Med 2013; 34:437-444
51. Wechsler ME, Laviolette M, Rubin AS, et al. Bronchial thermoplasty: Long-Term safety and effectiveness in patients with severe persistent asthma. J Allergy Clin Immunol 2013. [Epub ahead of print
52. Skloot G, Permutt S, Togias A. Airway hyperresponsiveness in asthma: A problem of limited smooth muscle relaxation with inspiration. J Clin Invest 1995; 96:2393-2403
53. Brown RH, Scichilone N, Mudge B, et al. High-resolution computed tomographic evaluation of airway distensibility and the effects of lung inflation on airway caliber in healthy subjects and individuals with asthma. Am J Respir Crit Care Med 2001; 163:994-1001
54. Holguin F, Cribbs S, Fitzpatrick AM, et al. A deep breath bronchoconstricts obese asthmatics. J Asthma 2010; 47:55-60
55. Jackson AC, Murphy MM, Rassulo J, et al. Deep breath reversal and exponential return of methacholine-induced obstruction in asthmatic and nonasthmatic subjects. J Appl Physiol 2004; 96:137-142
56. Lavoie TL, Dowell ML, Lakser OJ, et al. Disrupting actin-myosin-Actin connectivity in airway smooth muscle as a treatment for asthmä Proc Am Thorac Soc 2009; 6:295-300
57. Lakser OJ, Lindeman RP, Fredberg JJ. Inhibition of the p38 MAP kinase pathway destabilizes smooth muscle length during physiological loading. Am J Physiol Lung Cell Mol Physiol 2002; 282:L1117-L1121
58. Miron T, Vancompernolle K, Vandekerckhove J, et al. A 25-kD inhibitor of actin polymerization is a low molecular mass heat shock protein. J Cell Biol 1991; 114:255-261
59. Dowell ML, Lakser OJ, Gerthoffer WT, et al. Latrunculin B increases force fluctuation-induced relengthening of ACh-contracted, isotonically shortened canine tracheal smooth muscle. J Appl Physiol 2005; 98:489-497
60. Mahajan RK, Vaughan KT, Johns JA, Pardee JD. Actin filaments mediate Dictyostelium myosin assembly in vitro. Proc Natl Acad Sci U S A 1989; 86:6161-6165
61. Seow CY. Myosin filament assembly in an ever-changing myofilament lattice of smooth muscle. Am J Physiol Cell Physiol 2005; 289:C1363-C1368
62. Lavoie TL, Krishnan R, Siegel HR, et al. Dilatation of the constricted human airway by tidal expansion of lung parenchyma. Am J Respir Crit Care Med 2012; 186:225-232